机器人活体肝移植供肝切除术后生活质量:供者与受者决定因素的1年前瞻性分析
该前瞻性观察队列纳入2024年4月至2025年3月连续接受机器人供肝切除术的活体肝移植供者,不进行供者筛选。供者在术前及术后3、6、12个月完成SF-36、BIS和BDI问卷,评估纵向变化及相关因素。结果显示生理功能、角色生理、躯体疼痛和总体健康在3个月时下降,但12个月时恢复至基线;情绪健康和精力在6个月时超过基线并持续至12个月,体像障碍和抑郁症状始终较低。
要点
- 机器人供肝切除术后供者生理功能在3个月时下降,但12个月时恢复至基线水平。
- 情绪健康和精力在术后6个月时超过基线并持续至12个月,体像障碍和抑郁症状始终较低。
- 供者年龄较大与更好的心理社会结局轻度相关,供者并发症和受者早期死亡仅与部分领域短暂下降相关。
核心结论
- 机器人活体供肝切除术与术后第一年良好的生理和心理社会恢复相关,支持其以供者为中心的优势。
研究设计与样本
- 前瞻性观察队列研究,纳入2024年4月至2025年3月连续接受机器人供肝切除术的活体肝移植供者,不进行供者筛选,共分析214名供者(平均年龄36.4岁,54%男性)。
主要发现
- 生理功能、角色生理、躯体疼痛和总体健康在3个月时下降,但12个月时恢复至基线。
- 情绪健康和精力在6个月时超过基线并持续至12个月。
- 体像障碍和抑郁症状在整个随访期间保持较低水平。
- 供者年龄较大与更好的心理社会结局轻度相关。
- 供者并发症和受者早期死亡与部分领域短暂下降相关,但无持续影响;未观察到与移植物类型、供受者关系或受者疾病严重程度的一致关联。
临床怎么用
- 机器人供肝切除术可供所有供者选择而不经筛选,术后第一年供者生理和心理社会恢复良好。
- 术后3个月供者生理功能可能下降,但12个月内恢复,应关注早期康复支持。
- 供者年龄较大可能与更好的心理社会结局相关,供者并发症和受者早期死亡仅引起短暂影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Living liver donation is a major operation performed without direct medical benefit to the donor. Prospective data on longitudinal donor-reported outcomes after minimally invasive donor hepatectomy remain limited, particularly for robotic approaches offered without donor selection. METHODS: This prospective observational cohort study included all consecutive living liver donors undergoing robotic donor hepatectomy between April 2024 and March 2025. The robotic approach was offered to all donors without preselection. Donors completed the Short Form-36 (SF-36), Body Image Scale (BIS), and Beck Depression Inventory (BDI) questionnaires preoperatively and at 3, 6, and 12 months post-donation. Longitudinal changes relative to baseline were assessed using Wilcoxon signed-rank tests. Associations with donor demographics, perioperative variables, and recipient disease severity were evaluated using Spearman correlation and nonparametric group comparisons. RESULTS: A total of 214 donors were analyzed (mean age 36.4 y, 54% male). Physical Functioning, Role-Physical, Bodily Pain, and General Health declined at 3 months but recovered and returned to baseline by 12 months. Emotional Well-Being and Energy/Fatigue improved beyond baseline by 6 months and remained elevated at 12 months. Body image disturbance and depressive symptoms remained low throughout follow-up. Older donor age was modestly associated with better psychosocial outcomes. Donor complications and early recipient mortality were associated with transient reductions in selected domains without sustained impact. No consistent associations were observed with graft type, donor-recipient relationship, or recipient disease severity. CONCLUSIONS: Robotic living donor hepatectomy is associated with excellent physical and psychosocial recovery during the first postoperative year, supporting its donor-centered benefits.
引用
- Raptis DA, Alenazi M, Assubayii M, et al. Quality of Life After Robotic Living Donor Hepatectomy: A 1-Year Prospective Analysis of Donor and Recipient Determinants. Ann Surg. 2026. PMID: 42638324. doi:10.1097/SLA.0000000000007184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。